Identification of virulence determinants
OwnerRaul G. Barletta, N. Beth Harrisinventors
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for the determination of virulence determinants in bacteria and in particular bacteria of the genus Mycobacterium. Also disclosed are compositions and methods for stimulating an immune response in an animal using bacteria and virulence determinants identified by the methods of the present invention.
Claims53
A method for identifying virulence determinants of a bacteria comprising:
- introducing at least one mutation into the genome of a bacteria;
- culturing the mutated bacteria in the presence of an antimicrobial agent that kills growing but not non-growing bacteria;
- selecting surviving bacteria;
- testing the selected surviving bacteria for virulence;
- selecting the non virulent bacteria;
- sequencing genetic material from said selected non virulent bacteria;
- determining the site of mutation;
- and comparing the sequence at the mutated site to the corresponding wild type sequence.
A method for identifying virulence determinants in Mycobacterium paratuberculosis comprising:
- introducing at least one random mutation into the genome of a M. paratuberculosis bacteria by introduction of a transposon;
- infecting macrophages with said mutated bacteria culturing the macrophages containing said mutated bacteria in the presence of a fluoroquinolone or D-cycloserine;
- selecting surviving bacteria;
- testing the selected surviving bacteria for virulence in an animal;
- selecting the non virulent organisms;
- sequencing genetic material from said selected non virulent bacteria;
- determining the site of mutation;
- and
- comparing the sequence at the mutated site to the corresponding wild type sequence.
A composition for immunizing an animal against bacterial infection comprising:
- a pharmaceutically acceptable carrier, diluent or excipient;
- and at least one non-virulent strain of bacteria produced by the process comprising:
- introducing at least one mutation into the genome of a bacteria;
- culturing the mutated bacteria in the presence of an antimicrobial agent that kills growing but not non-growing bacteria;
- selecting surviving bacteria;
- testing the selected surviving bacteria for virulence;
- and selecting the non-virulent strains.
A composition for immunizing an animal against Mycobacterium paratuberculosis comprising:
- a pharmaceutically acceptable carrier, diluent or excipient;
- and at least one non-virulent strain of M. paratuberculosis produced by the process comprising:
- introducing at least one random mutation into the genome of a strain of M. paratuberculosis by insertion of a transposon;
- infecting macrophages with the mutated strain;
- culturing the infected macrophages in the presence of a fluoroquinolone or D-cycloserine;
- selecting surviving M. paratuberculosis organisms;
- testing the selected surviving organisms for virulence in an animal;
- and
- selecting the non-virulent strains.
A composition for immunizing an animal against a bacteria comprising:
- a pharmaceutically acceptable carrier diluent or excipient;
- and at least one bacterial virulence determinant, the determinant identified by a process comprising;
- introducing at least one mutation into the genome of a bacteria;
- culturing the mutated bacteria in the presence of an antimicrobial agent that kills growing but not non-growing bacteria;
- selecting surviving bacteria;
- testing the selected surviving bacteria for virulence;
- selecting the non-virulent strains;
- sequencing genetic material from the selected non-virulent bacteria to determine the site of the mutation;
- and
- identifying the virulence determinant based on the site of the mutation.
A composition for immunizing an animal against Mycobacterium paratuberculosis comprising:
- a pharmaceutically acceptable carrier diluent or excipient;
- and at least one Mycobacterium paratuberculosis virulence determinant, the determinant identified by a process comprising;
- introducing at least one mutation into the genome of a strain of Mycobacterium paratuberculosis by insertion of a transposon;
- infecting macrophages with the mutated strain;
- culturing the infected macrophages in the presence of a fluoroquinolone or D-cycloserine;
- selecting surviving bacteria;
- testing the selected surviving bacteria for virulence in an animal;
- selecting the non-virulent bacteria;
- sequencing genetic material from the selected non-virulent bacteria to determine the site of the mutation;
- and
- determining the virulence determinant based on the site of the mutation.
Dependencies are inferred from the claim text.